Home Mainline IPOs Modern Diagnostic IPO
Orion Industries logo

Modern Diagnostic IPO

Open Sme
BSE 31 December - 02 January 2026
Modern Diagnostic & Research Centre Limited IPO is a book build issue of 37 Cr. The issue is entirely a fresh issue of 4099200 shares aggregating to 37 Cr. Modern Diagnostic & Research Centre Limited IPO opened for subscription on Dec 31, 2025 and closed on Jan 02, 2026. The allotment for the this IPO was finalized on Jan 05, 2026. IPO was listed on NSE and BSE on Jan 07, 2026. Modern Diagnostic & Research Centre Limited IPO is set issue price band at ₹85 to ₹90 per share.

Current GMP

₹14 (+15.56%)

Price Band

₹ 85 – 90

Lot Size

1600

Issue Size

₹37 Cr

Minimum Investment

₹288000 (3200 Shares)

Listing Date

07 January 2026

Subscription

376.97x

About the Company

Modern Diagnostic & Research Centre Limited (MDRC), incorporated in 1985, is a well-established diagnostic services provider in India. The company operates a growing diagnostic chain offering a comprehensive range of pathology and radiology services to individuals, hospitals, and institutional clients.

MDRC is committed to delivering accurate, reliable, and timely diagnostic solutions, supported by advanced technology and experienced medical professionals. Its services include routine and specialized diagnostic testing, home specimen collection, online report access, and customized health packages tailored to the specific requirements of patients and institutional customers.

As of February 28, 2025, MDRC operates 21 centers across 8 Indian states, comprising 17 pathology laboratories and 4 full-fledged diagnostic centers. The company provides a broad spectrum of diagnostic services, including Ultrasound, CT Scan, MRI, X-Ray, ECG, Pulmonary Function Tests (PFT), as well as specialized diagnostic facilities for cardiac and neurological care.

Key Services

Pathology Services
MDRC offers an extensive range of pathology tests, from routine investigations to advanced and specialized diagnostics. These include high-end molecular diagnostics, cytogenetics, and specialized testing panels for genetic disorders, oncology, and other complex medical conditions.

Radiology Services
The company provides advanced imaging services such as MRI, CT scans, ultrasound, and digital X-rays, utilizing state-of-the-art equipment, including a 3-Tesla MRI system and a 128-slice CT scanner, ensuring high-quality imaging and accurate diagnosis.

Home Sample Collection
To enhance patient convenience, MDRC offers home blood sample collection services in multiple cities, catering especially to elderly patients, chronically ill individuals, and those unable to visit diagnostic centers.

Human Resources

As of February 28, 2025, MDRC has a total workforce of 570 employees, including qualified doctors, consultants, technical staff, and support personnel, who collectively contribute to maintaining high standards of diagnostic accuracy and patient care.

Promoters

  1. Mr. Devendra Singh Yadav
  2. Mrs. Deepali Yadav
  3. Mrs. Asha Yadav
  4. Mr. Jitendra Singh
Promoters Holding

Holding Pre Issue

99.99%

Holding Post Issue

72.85%

Objects of the Issue

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.

  1. Funding capital expenditure for purchase of medical equipment towards establishment of new diagnostic centre and labs 
  2. Funding Working Capital Requirement 
  3. Repayment of certain outstanding borrowings availed by our Company 
  4. General Corporate Expenses

Address / Contact Info

Modern Diagnostic & Research Centre Ltd. Address

Plot No H-64,1st Floor BLK-H,

Bali Nagar City landmark near Khetar Pal Hospital,

Ramesh Nagar, West Delhi

West Delhi, New Delhi, 110015

Phone: 9999474297

Email: compliance@mdrcindia.com

Website: http://www.mdrcindia.com/

IPO Snapshot

Face Value₹10 per share
Price Band₹ 85 – 90
Lot Size1600
Issue TypeBook-building IPO
Sale TypeFresh Capital
Fresh Issue₹ 37.00 Cr
Offer for Sale₹ 0.00 Cr
Total Issue Size₹ 37.00 Cr
Listing AtBSE
IndustryHealthcare Services
SectorHealthcare
QIB Quota28.65%
BNII Quota14.41%
SNII Quota7.03%
Retail Quota49.91%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Modern Diagnostic IPO is a Book-building IPO worth ₹37 crores. The price band is ₹85 to 90 per share. The IPO opens on Wed, Dec 31, 2025 and closes on Fri, Jan 2, 2026. It will be listed on BSE and NSE. MUFG Intime India Private Limited ((Link Intime) is the registrar.

The Modern Diagnostic IPO opens on Wed, Dec 31, 2025 and closes on Fri, Jan 2, 2026

Modern Diagnostic IPO Price Band is ₹85 to 90.

Modern Diagnostic IPO lot size is 1600, and the minimum amount required for application is ₹288000.

The minimum investment for Modern Diagnostic IPO is approximately ₹288000 based on the upper price band.

To apply for the Modern Diagnostic IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Fri, Jan 2, 2026. After submission, funds are blocked until the basis of allotment of Modern Diagnostic IPO is finalised.

Modern Diagnostic IPO issue size is ₹37 crores.

Modern Diagnostic IPO allotment date is Sat, Jun 27, 2026.

The registrar for Modern Diagnostic IPO is MUFG Intime India Private Limited ((Link Intime). Investors can go to MUFG Intime India Private Limited ((Link Intime) website for IPO allotment status, refund processing, and other queries related to Modern Diagnostic IPO through their official website or helpline.

The Modern Diagnostic IPO GMP (Grey Market Premium) is ₹14 as of Wed, Jan 7, 2026. Based on the upper price band of ₹90 per share, the estimated Modern Diagnostic IPO listing price is ₹104, indicating a potential listing gain of approximately 31% over the issue price.